(Q44486486)

3 December 2017

Efficacy of low-molecular-weight heparin in the management of intermittent claudication (English)

1 reference

3 December 2017

1 reference

1 reference

E Mannarino

1

1 reference

3 December 2017

L Pasqualini

2

1 reference

3 December 2017

S Innocente

3

1 reference

3 December 2017

U Orlandi

4

1 reference

3 December 2017

V Scricciolo

5

1 reference

3 December 2017

R Lombardini

6

1 reference

3 December 2017

G Ciuffetti

7

1 reference

3 December 2017

1 January 1991

1 reference

3 December 2017

1 reference

3 December 2017

42

1 reference

3 December 2017

1

1 reference

3 December 2017

1-7

1 reference

Heparin 1986. Indications and effective use.

3 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200101

Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200101

Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200101

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200101

Blood rheology in general medicine and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200101

Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200101

10.1177/000331979104200101

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference